Euclidean Capital’s Denali Therapeutics DNLI Stock Holding History

Euclidean Capital’s Portfolio DNLI Stock Details DNLI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell
2021 Q2	$25.4M	Hold
2021 Q1	$18.5M	Hold
2020 Q4	$27.1M	Buy